Tetsuya Kubota

Another HK Milestone For Transforming Customer Experience!    Robocore Technology has closed USD 30M Series D funding led by FTC (Foxconn Technology Co., Ltd.), marking another triumph for our robotics sector!   With a focus on healthcare spaces, Robocore's temi robots are already seen across 20,000 global client sites including retail spaces, campuses and households. In New York alone, over 200 elderly homes are experiencing lightning-fast remote diagnoses under two minutes, thanks to this technology.   This fresh capital will power Robocore's telemedicine expansion across the US, Europe, Japan, and mainland China, with an IPO targeted within five years.   #KeepUp, because Hong Kong keeps raising the bar!   Got an innovation that can make history? Get in touch and explore our investment platform: stp.hk/3UUxd1O   #HKSTP #PropellingSuccess #Investment #Robotics 

91

5件のコメント

🤝𝗦𝘂𝗺𝗶𝘁𝗼𝗺𝗼 𝗖𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗜𝗻𝘃𝗲𝘀𝘁𝘀 𝗶𝗻 𝗔𝗜-𝗯𝗮𝘀𝗲𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗥𝗮𝗱𝗶𝗮𝘁𝗶𝗼𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗦𝘁𝗮𝗿𝘁𝘂𝗽 𝗔𝗶𝗥𝗮𝘁𝗼 𝗮𝗻𝗱 𝗦𝗶𝗴𝗻𝘀 𝗘𝘅𝗰𝗹𝘂𝘀𝗶𝘃𝗲 𝗢𝘃𝗲𝗿𝘀𝗲𝗮𝘀 𝗗𝗶𝘀𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻 𝗔𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁🤝   Sumitomo Corporation has invested in AiRato Inc., a startup specializing in AI-based solutions for cancer radiation therapy. The two companies have concluded an exclusive overseas distribution agreement for AiRato's radiation therapy planning support software (hereinafter "AI planning software"). Sumitomo Corporation will work to ensure regulatory compliance across Asia, with plans to begin distribution in 2026.   ⚕️ The Current State of Cancer Radiation Therapy Large hospitals in medically advanced countries have adopted intensity-modulated radiation therapy (IMRT) for cancer treatment. IMRT minimizes damage to healthy tissue while delivering targeted radiation to cancer cells, reducing the burden on patients compared to conventional radiation therapy. However, creating a treatment plan for IMRT can take up to six hours per case, as it requires precise identification of the tumor's location from CT images and detailed calculation of radiation intensity and targeting.   ⚕️Strength of AI planning Software By applying AI trained on a vast dataset of past clinical cases, the AI planning software can identify tumors and radiation fields from CT images and cut treatment planning time from around six hours to just 20 minutes. This drastically improves efficiency for physicians and medical staff engaged in IMRT.   Sumitomo Corporation will leverage its global network and apply it to the rollout of AiRato's technology across the Asia region.   ▼Read more： https://lnkd.in/gVCxDF9P #AIinHealthcare #MedicalAI #digitaltransformation #Asia #SumitomoCorporation

99

1件のコメント

Featured article on Yuanhua Tech – OASES Enterprises in the life and health technology industry. Under its “Made in Hong Kong” brand strategy, Yuanhua completed the production of its first Hong Kong-made KUNWU® Orthopaedic Surgical Robot in November 2023. Yuanhua collaborates closely with the Department of Orthopaedics and Traumatology of The Chinese University of Hong Kong to promote the standardized application of orthopaedic surgical robots. To date, over 100 surgeries using KUNWU® have been performed in Hong Kong hospitals, promoting the development of health and medical innovation in Hong Kong. Discover more about Yuanhua’s pioneering innovations here: https://lnkd.in/gtvRVhRD #OfficeForAttractingStrategicEnterprises #OASES #StrategicEnterprises #LifeAndHealthTechnology #SurgeryRobot

35